167 related articles for article (PubMed ID: 23365687)
1. Substrate recognition and motion mode analyses of PFV integrase in complex with viral DNA via coarse-grained models.
Hu J; Liu M; Tang D; Chang S
PLoS One; 2013; 8(1):e54929. PubMed ID: 23365687
[TBL] [Abstract][Full Text] [Related]
2. Study on the interactions between diketo-acid inhibitors and prototype foamy virus integrase-DNA complex via molecular docking and comparative molecular dynamics simulation methods.
Hu JP; He HQ; Tang DY; Sun GF; Zhang YQ; Fan J; Chang S
J Biomol Struct Dyn; 2013; 31(7):734-47. PubMed ID: 22913375
[TBL] [Abstract][Full Text] [Related]
3. An effective HIV-1 integrase inhibitor screening platform: Rationality validation of drug screening, conformational mobility and molecular recognition analysis for PFV integrase complex with viral DNA.
Du W; Zuo K; Sun X; Liu W; Yan X; Liang L; Wan H; Chen F; Hu J
J Mol Graph Model; 2017 Nov; 78():96-109. PubMed ID: 29055187
[TBL] [Abstract][Full Text] [Related]
4. Insight into the binding mode between N-methyl pyrimidones and prototype foamy virus integrase-DNA complex by QM-polarized ligand docking and molecular dynamics simulations.
Reddy KK; Singh SK
Curr Top Med Chem; 2015; 15(1):43-9. PubMed ID: 25579571
[TBL] [Abstract][Full Text] [Related]
5. Molecular dynamics approaches estimate the binding energy of HIV-1 integrase inhibitors and correlate with in vitro activity.
Johnson BC; Métifiot M; Pommier Y; Hughes SH
Antimicrob Agents Chemother; 2012 Jan; 56(1):411-9. PubMed ID: 22037850
[TBL] [Abstract][Full Text] [Related]
6. Close-up: HIV/SIV intasome structures shed new light on integrase inhibitor binding and viral escape mechanisms.
Engelman AN; Cherepanov P
FEBS J; 2021 Jan; 288(2):427-433. PubMed ID: 32506843
[TBL] [Abstract][Full Text] [Related]
7. C-Terminal Domain of Integrase Binds between the Two Active Sites.
Roberts VA
J Chem Theory Comput; 2015 Sep; 11(9):4500-11. PubMed ID: 26575940
[TBL] [Abstract][Full Text] [Related]
8. Novel HIV integrase inhibitors with anti-HIV activity: insights into integrase inhibition from docking studies.
Cox AG; Nair V
Antivir Chem Chemother; 2006; 17(6):343-53. PubMed ID: 17249248
[TBL] [Abstract][Full Text] [Related]
9. A homology model of HIV-1 integrase and analysis of mutations designed to test the model.
Johnson BC; Métifiot M; Ferris A; Pommier Y; Hughes SH
J Mol Biol; 2013 Jun; 425(12):2133-46. PubMed ID: 23542006
[TBL] [Abstract][Full Text] [Related]
10. Novel bifunctional quinolonyl diketo acid derivatives as HIV-1 integrase inhibitors: design, synthesis, biological activities, and mechanism of action.
Di Santo R; Costi R; Roux A; Artico M; Lavecchia A; Marinelli L; Novellino E; Palmisano L; Andreotti M; Amici R; Galluzzo CM; Nencioni L; Palamara AT; Pommier Y; Marchand C
J Med Chem; 2006 Mar; 49(6):1939-45. PubMed ID: 16539381
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of novel β-diketo derivatives as HIV-1 integrase inhibitors.
Hu L; Zhang S; He X; Luo Z; Wang X; Liu W; Qin X
Bioorg Med Chem; 2012 Jan; 20(1):177-82. PubMed ID: 22154762
[TBL] [Abstract][Full Text] [Related]
12. Integrase Inhibitor Prodrugs: Approaches to Enhancing the Anti-HIV Activity of β-Diketo Acids.
Nair V; Okello M
Molecules; 2015 Jul; 20(7):12623-51. PubMed ID: 26184144
[TBL] [Abstract][Full Text] [Related]
13. Dissecting Tn5 transposition using HIV-1 integrase diketoacid inhibitors.
Czyz A; Stillmock KA; Hazuda DJ; Reznikoff WS
Biochemistry; 2007 Sep; 46(38):10776-89. PubMed ID: 17725323
[TBL] [Abstract][Full Text] [Related]
14. Prediction of the binding mode and resistance profile for a dual-target pyrrolyl diketo acid scaffold against HIV-1 integrase and reverse-transcriptase-associated ribonuclease H.
Yang F; Zheng G; Fu T; Li X; Tu G; Li YH; Yao X; Xue W; Zhu F
Phys Chem Chem Phys; 2018 Sep; 20(37):23873-23884. PubMed ID: 29947629
[TBL] [Abstract][Full Text] [Related]
15. Synthesis, docking, and biological studies of phenanthrene β-diketo acids as novel HIV-1 integrase inhibitors.
Sharma H; Sanchez TW; Neamati N; Detorio M; Schinazi RF; Cheng X; Buolamwini JK
Bioorg Med Chem Lett; 2013 Nov; 23(22):6146-51. PubMed ID: 24091080
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 integrase and virus and cell DNAs: complex formation and perturbation by inhibitors of integration.
Hobaika Z; Zargarian L; Maroun RG; Mauffret O; Burke TR; Fermandjian S
Neurochem Res; 2010 Jun; 35(6):888-93. PubMed ID: 19937113
[TBL] [Abstract][Full Text] [Related]
17. Homology model-guided 3D-QSAR studies of HIV-1 integrase inhibitors.
Sharma H; Cheng X; Buolamwini JK
J Chem Inf Model; 2012 Feb; 52(2):515-44. PubMed ID: 22256860
[TBL] [Abstract][Full Text] [Related]
18. New developments in diketo-containing inhibitors of HIV-1 integrase.
Zhao G; Wang C; Liu C; Lou H
Mini Rev Med Chem; 2007 Jul; 7(7):707-25. PubMed ID: 17627583
[TBL] [Abstract][Full Text] [Related]
19. Structural Studies of the HIV-1 Integrase Protein: Compound Screening and Characterization of a DNA-Binding Inhibitor.
Quashie PK; Han YS; Hassounah S; Mesplède T; Wainberg MA
PLoS One; 2015; 10(6):e0128310. PubMed ID: 26046987
[TBL] [Abstract][Full Text] [Related]
20. N-Substituted Quinolinonyl Diketo Acid Derivatives as HIV Integrase Strand Transfer Inhibitors and Their Activity against RNase H Function of Reverse Transcriptase.
Pescatori L; Métifiot M; Chung S; Masoaka T; Cuzzucoli Crucitti G; Messore A; Pupo G; Madia VN; Saccoliti F; Scipione L; Tortorella S; Di Leva FS; Cosconati S; Marinelli L; Novellino E; Le Grice SF; Pommier Y; Marchand C; Costi R; Di Santo R
J Med Chem; 2015 Jun; 58(11):4610-23. PubMed ID: 25961960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
